rs4143815-PDL1, a New Potential Immunogenetic Biomarker of Biochemical Recurrence in Locally Advanced Prostate Cancer after Radiotherapy

Zanusso, C; Dreussi, E; Bortolus, R; Romualdi, C; Gagno, S; De Mattia, E; Romanato, L; Sartor, F; Quartuccio, L; Cecchin, E; Toffoli, G

Toffoli, G (reprint author), Ctr Riferimento Oncol Aviano CRO, Expt & Clin Pharmacol, IRCCS, I-33081 Aviano, Italy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019; 20 (9):

Abstract

Up to 30-50% of patients with locally advanced prostate cancer (PCa) undergoing radiotherapy (RT) experience biochemical recurrence (BCR). The immune ......

Full Text Link